Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.94 USD | +2.80% | +11.70% | +48.14% |
04-30 | Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer | CI |
02-09 | Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.14% | 294M | |
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+45.32% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |
- Stock Market
- Equities
- ENTA Stock
- News Enanta Pharmaceuticals, Inc.
- Enanta Pharmaceuticals Files Patent Lawsuit Against Pfizer Over COVID-19 Antiviral -- Shares Jump in Pre-Market